Neuromon B.V. is licensed for the implementation of the so-called PaR-technology.

PaR-technology is an alternative way to express cerebral hemodynamic state by calculating a combined index based upon a continuous registration of arterial blood pressure, as the driving force, and middle cerebral artery flow velocity, as resultant. The pulsatile apparent resistance (PaR) can be seen as a blood pressure corrected pulsatility index (PI).

The PaR is negative when cerebral autoregulation is exhausted. It varies between 0 and 0.5 in the normal situation and reaches values higher than 0.5 in intracranial hypertension.

In the EU, PaR-technology was filed in the Netherlands, Belgium, Great Britain, France and Germany.

Outside the EU PaR-technology was filed in the EU, USA, Canada and Australia (WO2005102158A1).


EU: EP1755444A1

NL: P68461NLEP10

BE: P68461BEEP10

DE: 60 2005 056 940.5

GB: EP1755444

FR: EP1755444

USA: US2007293760A1

CA: CA2564059A1

AU: AU2005235162A1


We use cookies

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.